Extracorporeal Shockwave Therapy (ESWT) has long been a standard method for breaking kidney stones. Experimental studies on cardiac tissue and coronary arteries have demonstrated that low-intensity shockwave therapy promotes new blood vessel formation (neovascularization) and increases blood flow. Building on these findings, low-intensity shockwave therapy has been adapted for use on the penile artery and tissue, which share similar characteristics with coronary vessels, particularly in the context of erectile dysfunction (ED).
While the underlying principle is similar to the system used for kidney stone fragmentation, the shockwave therapy applied for sexual dysfunction treatment utilizes significantly lower intensity. Consequently, there are no known side effects or harms associated with low-intensity shockwave therapy for erectile dysfunction.
It is crucial to thoroughly evaluate each patient to determine suitability and recommend this treatment alternative to those who stand to benefit most. In patients with Peyronie's disease, especially during the initial painful phase, applying this therapy is significant as it can help prevent plaque formation. Nevertheless, it is important to acknowledge that this treatment method is relatively new, and its long-term positive outcomes are still being established.